Valerio G Vellone
Overview
Explore the profile of Valerio G Vellone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herzum A, Viglizzo G, Occella C, Gariazzo L, Vellone V, Orsi S, et al.
Ital J Dermatol Venerol
. 2024 Oct;
PMID: 39360802
Introduction: Lichen striatus (LS) is an acquired blaschkitis, with typical linear and unilateral distribution. It occurs mainly in children and is self-resolving, yet its etiopathogenesis remains widely unknown. Evidence Acquisition:...
2.
Greppi M, De Franco F, Obino V, Rebaudi F, Goda R, Frumento D, et al.
Immunol Lett
. 2024 Sep;
270:106932.
PMID: 39303993
Natural Killer (NK) cells are integral to the innate immune system, renowned for their ability to target and eliminate cancer cells without the need for antigen presentation, sparing normal tissues....
3.
Ventura F, Drommi M, Barranco R, Vellone V
Med Leg J
. 2024 Jul;
:258172241250193.
PMID: 39075857
Septic cerebral venous sinus thrombosis is a rare but often fatal complication caused by bacterial meningitis and paranasal sinusitis.We report a particular case of the sudden and unexpected death of...
4.
Capasso M, Brignole C, Lasorsa V, Bensa V, Cantalupo S, Sebastiani E, et al.
J Transl Med
. 2024 Feb;
22(1):151.
PMID: 38351008
Background: Neuroblastoma (NB) represents the most frequent and aggressive form of extracranial solid tumor of infants. Although the overall survival of patients with NB has improved in the last years,...
5.
Scavone G, Ottonello S, Blondeaux E, Arecco L, Scaruffi P, Stigliani S, et al.
Cancers (Basel)
. 2023 Oct;
15(20).
PMID: 37894292
The combination of cyclin-dependent kinase (CDK) 4/6 inhibitors with endocrine therapy is the standard treatment for patients with HR+/HER2- advanced breast cancer. Recently, this combination has also entered the early...
6.
Herzum A, Occella C, Pastorino C, Gariazzo L, Vercellino N, Vellone V, et al.
Ital J Dermatol Venerol
. 2023 Sep;
158(6):498-499.
PMID: 37750846
No abstract available.
7.
Biatta C, Paudice M, Greppi M, Parrella V, Parodi A, De Luca G, et al.
Front Immunol
. 2023 Sep;
14:1221605.
PMID: 37680633
Background: we evaluated the concordance between immunohistochemical p53 staining and TP53 mutations in a series of HGSOC. Moreover, we searched for prognostic differences between p53 overexpression and null expression groups....
8.
Sahnane N, Rivera D, Libera L, Carnevali I, Banelli B, Facchi S, et al.
J Mol Diagn
. 2023 Feb;
25(4):217-226.
PMID: 36739964
Epithelial ovarian cancers (EOCs) harboring germline or somatic pathogenic variants in BRCA1 and BRCA2 genes show sensitivity to poly(ADP-ribose) polymerase inhibition. It has been suggested that BRCA1 promoter methylation is...
9.
Merlo G, Cozzani E, Comandini D, Trave I, Centurioni M, Franchelli S, et al.
Dermatol Ther
. 2021 Feb;
34(2):e14860.
PMID: 33559311
No abstract available.
10.
SIRT6 enhances oxidative phosphorylation in breast cancer and promotes mammary tumorigenesis in mice
Becherini P, Caffa I, Piacente F, Damonte P, Vellone V, Passalacqua M, et al.
Cancer Metab
. 2021 Jan;
9(1):6.
PMID: 33482921
Background: Sirtuin 6 (SIRT6) is a NAD-dependent deacetylase with key roles in cell metabolism. High SIRT6 expression is associated with adverse prognosis in breast cancer (BC) patients. However, the mechanisms...